Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subconjunctival epinephrine for mydriasis maintenance during posterior vitrectomy
RBR-3qzhvgCompleted
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Nov 2017
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of epinephrine in retinal diseases and Pupil anomaly (2 arms), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Primary endpoints: Change in pupil diameter and Intraoperative fundus visualization. Started Nov 2017; status: completed.
02
Drugs
epinephrine
03
Conditions
retinal diseasesPupil anomaly
Beyond the preview
Go deeper on RBR-3qzhvg.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-3qzhvg.